| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,922 | 4,009 | 1,926 | 2,489 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 3,922 | 4,009 | 1,926 | 2,489 | | | Operating Expenses | | Research Development | 4,828 | 4,713 | 2,697 | 3,423 | | Selling General and Administrative | 1,907 | 1,802 | 2,060 | 1,613 | | Non Recurring | (194) | 84 | 109 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,619) | (2,590) | (2,940) | (2,547) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,191 | (7,763) | (3,944) | 976 | | Earnings Before Interest And Taxes | (1,429) | (10,353) | (6,885) | (1,571) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,429) | (10,353) | (6,885) | (1,571) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,429) | (10,353) | (6,885) | (1,571) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,429) | (10,353) | (6,885) | (1,571) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,429) | ($10,353) | ($6,885) | ($1,571) |
|
0.18% Nasdaq 
0.42%
Income Statement
